Beam Therapeutics BEAM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Business | ||||||
| Employee Related Expenses | $32.87M0.0% | $32.86M+18.9% | $27.64M0.0% | $27.62M-5.5% | $29.24M+7.1% | |
| External Research And Development Expenses | $30.08M-13.6% | $34.82M+3.7% | $33.57M-15.9% | $39.89M+15.9% | $34.42M+6.9% | |
| General And Administrative Expense by Business | ||||||
| Employee Related Expenses | $11.95M-4.7% | $12.55M+23.7% | $10.15M+1.5% | $9.99M-4.3% | $10.44M+5.3% | |
| External General And Administrative Expenses | $13.37M+32.9% | $10.05M+52.6% | $6.59M+4.6% | $6.3M+17.3% | $5.37M-15.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Beam Therapeutics break its business down?
- Beam Therapeutics (BEAM) reports research and development expense by business across 2 parts — Employee Related Expenses and External Research And Development Expenses. Each is extracted from the segment footnotes and tracked over time.
- Where does Beam Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Beam Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.